Get the Stockscreener App
1.33
6.40%
0.08
Allarity Therapeutics Inc stock is traded at $1.33, with a volume of 120.64K.
It is up +6.40% in the last 24 hours and down -8.90% over the past month.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
See More
Previous Close:
$1.25
Open:
$1.24
24h Volume:
120.64K
Relative Volume:
0.13
Market Cap:
$21.03M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.00646
EPS:
-206.0125
Net Cash Flow:
$-12.75M
1W Performance:
+25.47%
1M Performance:
-8.90%
6M Performance:
+43.33%
1Y Performance:
+19.82%
1-Day Range:
$1.24
$1.35
1-Week Range:
$1.07
$1.35
52-Week Range:
$0.6138
$2.35
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Name
Allarity Therapeutics Inc
Sector
Industry
Phone
401-426-4664
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Compare ALLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
1.33 | 19.76M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Stock (ALLR) Latest News
How Allarity Therapeutics Inc. stock trades before earningsJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - moha.gov.vn
Published on: 2025-11-28 11:27:30 - moha.gov.vn
Is Allarity Therapeutics Inc. stock a buy before product launchesJuly 2025 Sector Moves & Fast Gaining Stock Reports - moha.gov.vn
A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews
Allarity Therapeutics Inc. (ALLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Allarity Therapeutics, Inc. (ALLR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is it too late to sell Allarity Therapeutics Inc.July 2025 Movers & High Yield Equity Trading Tips - newser.com
How Allarity Therapeutics Inc. stock performs in weak economyShare Buyback & Verified Momentum Stock Watchlist - newser.com
Will Allarity Therapeutics Inc. stock continue upward momentumJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Why Allarity Therapeutics Inc. stock appeals to analystsPortfolio Performance Report & Technical Pattern Based Signals - newser.com
Why retail investors pile into Allarity Therapeutics Inc. stockWeekly Loss Report & Verified Momentum Stock Ideas - newser.com
How Allarity Therapeutics Inc. stock reacts to oil pricesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Applying big data sentiment scoring on Allarity Therapeutics Inc.July 2025 Summary & Fast Momentum Entry Tips - newser.com
Exit strategy if you’re trapped in Allarity Therapeutics Inc.Market Sentiment Summary & Daily Profit Focused Stock Screening - newser.com
Published on: 2025-11-19 00:17:48 - newser.com
Why hedge funds are buying Allarity Therapeutics Inc. stock2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Real time breakdown of Allarity Therapeutics Inc. stock performanceMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Is Allarity Therapeutics Inc. stock affected by interest rate hikesJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com
Allarity Therapeutics Inc Stock Analysis and ForecastTake Profit Strategies & Smart Trading Plans for Every Investor Type - earlytimes.in
Using AI based signals to follow Allarity Therapeutics Inc.Earnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Can momentum traders help lift Allarity Therapeutics Inc.Quarterly Trade Review & Short-Term High Return Strategies - newser.com
Published on: 2025-11-15 17:56:44 - newser.com
Published on: 2025-11-14 20:27:35 - newser.com
Real time pattern detection on Allarity Therapeutics Inc. stockWeekly Investment Report & Verified Momentum Watchlists - newser.com
Key facts: Allarity Therapeutics reports $7.9M Q3 loss; R&D expenses rise - TradingView
What earnings revisions data tells us about Allarity Therapeutics Inc.Index Update & Risk Controlled Swing Trade Alerts - newser.com
Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates - Investing News Network
Allarity Therapeutics's Q3 net loss narrows - MarketScreener
Allarity Therapeutics Inc Stock (ALLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):